Abstract
The aim of this study is to investigate the effect of tyrosine kinase Src on Tyrosine 307(Y307) phosphorylation, protein phosphatase 2A (PP2A) activity, and on tau phosphorylation. Specific Src siRNA was transfected into cultured mouse neuroblastoma N2a cells to inhibit the expression of Src protein, and the phosphorylation levels of PP2A Y307 and tau at different sites, as well as PP2A activity were detected at different time points after siRNA transfection. Twelve hours after siRNA transfection, the protein level of Src was dramatically decreased, with decreased PP2A Y307 phosphorylation. However, the total PP2A protein level was also decreased, together with a decreased PP2A activity. Tau was hyperphosphorylated at the Ser198/199/202 sites. Multiple factors may be involved in the cellular regulation of PP2A activity. Inhibiting Src expression could induce inactivation of PP2A and tau hyperphosphorylation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arriagada P V, Growdon J H, Hedley-Whyte E T, Hyman B T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology, 1992, 42(3): 631–639
Grundke-Iqbal I, Iqbal K, Tung Y C, Quinlan M, Wisniewski H M, Binder L I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA, 1986, 83(13): 4913–4917
Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J, 2001, 353(Pt 3): 417–439
Liu F, Grundke-Iqbal I, Iqbal K, Gong C X. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci, 2005, 22(8): 1942–1950
Gong C X, Singh T J, Grundke-Iqbal I, Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem, 1993, 61(3):921–927
Liu F, Liang Z, Gong C X. Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease. Panminerva Med, 2006, 48(2): 97–108
Sontag E, Hladik C, Montgomery L, Luangpirom A, Mudrak I, Ogris E, White C L 3rd: Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J Neuropathol Exp Neurol, 2004, 63(10): 1080–1091
Chen J, Martin B L, Brautigan D L. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science, 1992, 257(5074): 1261–1264
Pei J J, Gong C X, Iqbal K, Grundke-Iqbal I, Wu Q L, Winblad B, Cowburn R F. Subcellular distribution of protein phosphatases and abnormally phosphorylated tau in the temporal cortex from Alzheimer’s disease and control brains. J Neural Transm, 1998, 105(1): 69–83
Garcia A, Cayla X, Guergnon J, Dessauge F, Hospital V, Rebollo MP, Fleischer A, Rebollo A. Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis. Biochimie, 2003, 85(8): 721–726
Gong C X, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer’s disease. J Biol Chem, 2000, 275(8): 5535–5544
Sontag E, Nunbhakdi-Craig V, Lee G, Bloom G S, Mumby M C. Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron, 1996, 17(6): 1201–1207
Author information
Authors and Affiliations
Corresponding authors
Additional information
The authors contributed equally to the study.
Rights and permissions
About this article
Cite this article
Liu, R., Zeng, J., Zhou, X. et al. Effect of inhibiting tyrosine kinase Src expression on protein phosphatase 2A and tau phosphorylation. Front. Med. China 2, 235–238 (2008). https://doi.org/10.1007/s11684-008-0044-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11684-008-0044-8